ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $33.6M

      Shares

      10.3M

      % of Portfolio

      0.57%

      Average Buy Price

      $2.16

      Avg closing price
      Price range

      6 Jefferies Group Taysha Gene Therapies Trades

      Jefferies Group acquired 10.3M Taysha Gene Therapies shares worth $33.6M. That's 0.57% of their equity portfolio (42nd largest holding). The investor owns 8.16% of the outstanding Taysha Gene Therapies stock. The first Taysha Gene Therapies trade was made in Q1 2024. Since then Jefferies Group bought shares three more times and sold shares on two occasions. The stake costed the investor $22.3M, netting the investor a gain of 51% so far.

      Avg closing price
      Price range
      Increased shares by 4105.3% (+10.1M shares) Q2 2025
      Avg closing price $2.17
      Price range $1.13 - $2.93
      New holding (+245k shares) Q1 2025
      Avg closing price $1.67
      Price range $1.39 - $2.05
      Sold -73.9k shares Q4 2024
      Avg closing price $2.08
      Price range $1.27 - $3.24
      Sold 71.3% shares (-184k shares) Q3 2024
      Avg closing price $2.19
      Price range $2.01 - $2.46
      Increased shares by 435.7% (+210k shares) Q2 2024
      Avg closing price $2.91
      Price range $2.04 - $4.17
      New holding (+48.1k shares) Q1 2024
      Avg closing price $2.08
      Price range $1.43 - $3.25

      News about Taysha Gene Therapies Inc and Jefferies Group

      Vanguard Group Inc. Has $13.33 Million Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

      Vanguard Group Inc. Has $13.33 Million Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

      Vanguard Group Inc. grew its position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) by 36.6% during the second quarter, according to its most recent...

      Transcript Daily Transcript Daily, almost 4 years ago
      Legal & General Group Plc Acquires 2,835 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

      Legal & General Group Plc Acquires 2,835 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

      Legal & General Group Plc grew its holdings in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) by 310.2% in the 2nd quarter, according to its most recent...

       Dakota Financial News Dakota Financial News, almost 4 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×